Patents Assigned to OXALYS PHARMACEUTICALS
  • CHEMICAL SUPPRESSORS OF NEUROTOXICITY IN SYNUCLEINOPATHIC DISEASES
    Publication number: 20150148369
    Abstract: The current application relates to the use of a compound selected from the group consisting of camptothecin and its analog, 10-hydroxy camptothecin, topotecan, irinotecan, 18-beta-glycyrrhetinic acid and its analog, carbinoxolone, etoposide, topoisomerase inhibitors, and combinations thereof, for the treatment of a synucleinopathy disease or disorder such as Parkinson's disease.
    Type: Application
    Filed: May 31, 2013
    Publication date: May 28, 2015
    Applicant: OXALYS PHARMACEUTICALS
    Inventors: Katharine Julia Sepp, Joost Schulte